Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anca Barău Abu Alhija"'
Autor:
Ion Cristian Efrem, Maria Moța, Ionela Mihaela Vladu, Adina Mitrea, Diana Clenciu, Diana Cristina Protasiewicz Timofticiuc, Ileana-Diana Diaconu, Adina Turcu, Anda Elena Crișan, Cristiana Geormăneanu, Adina Dorina Glodeanu, Beatrice Mahler, Marinela Sînziana Tudor, Anca Maria Amzolini, Simona Elena Micu, Anca Barău Abu Alhija, Adrian Mită, Maria Monalisa Filip, Maria Forțofoiu
Publikováno v:
Diagnostics, Vol 12, Iss 10, p 2426 (2022)
Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new term that no longer excludes patients that consume alcohol or present other liver diseases, unlike nonalcoholic fatty liver disease (NAFLD). The aim of this study was to evaluate t
Externí odkaz:
https://doaj.org/article/02e242f5f6594ae78f6b0e5ec399383c
Autor:
Anca Maria, Amzolini, Mircea Cătălin, Forţofoiu, Anca, Barău Abu-Alhija, Ionela Mihaela, Vladu, Diana, Clenciu, Adina, Mitrea, Maria, Forţofoiu, Daniela, Matei, Viorela, Enăchescu, Octavian Ion, Predescu, Elena Simona, Micu
Publikováno v:
Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie. 62(2)
Non-alcoholic fatty liver disease (NAFLD) is associated with metabolic impairments, being a component of metabolic syndrome. Considering the involvement of fat accumulation and insulin resistance in NAFLD, triglyceride and glucose (TyG) index was pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92ddaaeebd0eb0175e68f85116309ce3
https://pubmed.ncbi.nlm.nih.gov/35024735
https://pubmed.ncbi.nlm.nih.gov/35024735
Autor:
Elena Simona, Micu, Anca Maria, Amzolini, Anca, Barău Abu-Alhija, Mircea Cătălin, Forţofoiu, Ionela Mihaela, Vladu, Diana, Clenciu, Adina, Mitrea, Stelian Ştefăniţă, Mogoantă, Anda Elena, Crişan, Octavian Ion, Predescu, Mirela, Radu
Publikováno v:
Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie. 62(2)
Non-alcoholic steatohepatitis (NASH) is a progressive form of liver steatosis that involves a risk of progression towards fibrosis, cirrhosis, and end-stage liver disease. Low-grade inflammation is recognized to be involved in non-alcoholic fatty liv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::238e51833a0f52f6eb6bf39f3ae6a996
https://pubmed.ncbi.nlm.nih.gov/35024739
https://pubmed.ncbi.nlm.nih.gov/35024739